Alector, Inc.

SOUTH SAN FRANCISCO, CA How do I update this listing?

Alector is based out of South San Francisco. Alector, Inc. operates as a clinical stage biopharmaceutical company. The Company researches and develops novel therapeutics for the treatment of neurodegeneration and other brain disorders. Alector offers its services in the State of California. The firm last filed a Form D notice of exempt offering of securities on 2015-09-16. The notice included securities offered of Equity

Create Alert

Contact Info

alector, inc.
151 OYSTER POINT BLVD., SUITE 300
SOUTH SAN FRANCISCO CA    94080

Business Phone: 415-231-5660
SEC SIC CODE:
2836-BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2015-09-16 D BIOTECHNOLOGY Equity 32,275,003 32,275,003 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
ARNON ROSENTHAL subscription required
    EXECUTIVE OFFICER DIRECTOR
CARL GORDON subscription required
    DIRECTOR
TERRY MCGUIRE subscription required
    DIRECTOR
TILLMAN GERNGROSS subscription required
    DIRECTOR

Elevate your investments